Sullivan, Bruyette, Speros & Blaney’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$197K Sell
14,079
-1,294
-8% -$21.1K 0.01% 310
2020
Q4
$288K Buy
+15,373
New +$251K 0.01% 231

Other funds holding VTRS

Sullivan, Bruyette, Speros & Blaney's VTRS Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney reduced its Viatris (VTRS) stake by 8.4% in Q1 2021, selling an estimated $21.1K and leaving 14,079 shares worth $197K. The position accounts for 0.01% of the portfolio, ranked #310.

Sullivan, Bruyette, Speros & Blaney first reported a position in VTRS in Q4 2020 and has held it in 2 quarters since. The position peaked at $288K in Q4 2020. 1,116 funds tracked by Wall St. Rank hold VTRS as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 14,079 shares of Viatris worth $197K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney sold 1,294 Viatris shares in Q1 2021, an estimated $21.1K.
  • Viatris made up 0.01% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #310 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Viatris in Q4 2020 and has held it in 2 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Viatris position peaked at $288K in Q4 2020.
  • 1,116 funds tracked by Wall St. Rank held Viatris as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.